APO Research
Talk to an analyst

APO RESEARCH · REPORT

Inhalation Pulmonary Drug Delivery Devices

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Inhalation Pulmonary Drug Delivery Devices Market Outlook and Growth Opportunities 2026

29 December 2025193 pages

Choose your research edition.

Industry ResearchInhalation Pulmonary Drug Delivery Devices Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Inhalation Pulmonary Drug Delivery Devices Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Inhalation Pulmonary Drug Delivery Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Inhalation Pulmonary Drug Delivery Devices Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Inhalation Pulmonary Drug Delivery Devices Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Inhalation Pulmonary Drug Delivery Devices market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Inhalation Pulmonary Drug Delivery Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Inhalation Pulmonary Drug Delivery Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Inhalation Pulmonary Drug Delivery Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Inhalation Pulmonary Drug Delivery Devices market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Inhalation Pulmonary Drug Delivery Devices market include AptarGroup, Boehringer Ingelheim, Chiesi Farmaceutici, H&T Presspart, Koninklijke Philips, Monaghan Medical, OMRON, PARI International and Vectura, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Inhalation Pulmonary Drug Delivery Devices market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Inhalation Pulmonary Drug Delivery Devices and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Inhalation Pulmonary Drug Delivery Devices sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Inhalation Pulmonary Drug Delivery Devices market size, projected growth trends, production technologies, key applications, and end-use industries.

Inhalation Pulmonary Drug Delivery Devices Segment by Company

AptarGroup

Boehringer Ingelheim

Chiesi Farmaceutici

H&T Presspart

Koninklijke Philips

Monaghan Medical

OMRON

PARI International

Vectura

AstraZeneca

GlaxoSmithKline (GSK)

Viatris

Merck

Novartis

Teva Pharmaceutical Industries

Inhalation Pulmonary Drug Delivery Devices Segment by Type

Nebulizers

Dry-powder Inhalers

Metered- dose Inhalers

Inhalation Pulmonary Drug Delivery Devices Segment by Application

Chronic Obstructive Pulmonary Disease (COPD)

Cystic Fibrosis (CF)

Idiopathic Pulmonary Fibrosis (IPF)

Asthma

Others

Inhalation Pulmonary Drug Delivery Devices Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Inhalation Pulmonary Drug Delivery Devices status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Inhalation Pulmonary Drug Delivery Devices market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Inhalation Pulmonary Drug Delivery Devices significant trends, drivers, influence factors in global and regions.

6. To analyze Inhalation Pulmonary Drug Delivery Devices competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Inhalation Pulmonary Drug Delivery Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Inhalation Pulmonary Drug Delivery Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Inhalation Pulmonary Drug Delivery Devices.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Inhalation Pulmonary Drug Delivery Devices market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Inhalation Pulmonary Drug Delivery Devices industry.

Chapter 3: Detailed analysis of Inhalation Pulmonary Drug Delivery Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Inhalation Pulmonary Drug Delivery Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Inhalation Pulmonary Drug Delivery Devices in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Inhalation Pulmonary Drug Delivery Devices Industry Trends Table 2. Inhalation Pulmonary Drug Delivery Devices Industry Drivers Table 3. Inhalation Pulmonary Drug Delivery Devices Industry Opportunities and Challenges Table 4. Inhalation Pulmonary Drug Delivery Devices Industry Restraints Table 5. Global Inhalation Pulmonary Drug Delivery Devices Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Inhalation Pulmonary Drug Delivery Devices Revenue Share by Company (2021-2026) Table 7. Global Inhalation Pulmonary Drug Delivery Devices Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Inhalation Pulmonary Drug Delivery Devices Sales Volume Share by Company (2021-2026) Table 9. Global Inhalation Pulmonary Drug Delivery Devices Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Inhalation Pulmonary Drug Delivery Devices Company Ranking, (2024-2026) & (USD Million) Table 11. Global Inhalation Pulmonary Drug Delivery Devices Key Company Manufacturing Base & Headquarters Table 12. Global Inhalation Pulmonary Drug Delivery Devices Company, Product Type & Application Table 13. Global Inhalation Pulmonary Drug Delivery Devices Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Inhalation Pulmonary Drug Delivery Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Nebulizers Table 18. Significant Companies of Dry-powder Inhalers Table 19. Significant Companies of Metered- dose Inhalers Table 20. Global Inhalation Pulmonary Drug Delivery Devices Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Inhalation Pulmonary Drug Delivery Devices Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Inhalation Pulmonary Drug Delivery Devices Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Inhalation Pulmonary Drug Delivery Devices Sales Volume Share by Type (2021-2026) Table 24. Global Inhalation Pulmonary Drug Delivery Devices Sales Volume Share by Type (2027-2032) Table 25. Global Inhalation Pulmonary Drug Delivery Devices Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Inhalation Pulmonary Drug Delivery Devices Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Inhalation Pulmonary Drug Delivery Devices Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Type (2021-2026) Table 29. Global Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Chronic Obstructive Pulmonary Disease (COPD) Table 31. Significant Companies of Cystic Fibrosis (CF) Table 32. Significant Companies of Idiopathic Pulmonary Fibrosis (IPF) Table 33. Significant Companies of Asthma Table 34. Significant Companies of Others Table 35. Global Inhalation Pulmonary Drug Delivery Devices Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Inhalation Pulmonary Drug Delivery Devices Sales Volume by Application (2021-2026) & (K Units) Table 37. Global Inhalation Pulmonary Drug Delivery Devices Sales Volume by Application (2027-2032) & (K Units) Table 38. Global Inhalation Pulmonary Drug Delivery Devices Sales Volume Share by Application (2021-2026) Table 39. Global Inhalation Pulmonary Drug Delivery Devices Sales Volume Share by Application (2027-2032) Table 40. Global Inhalation Pulmonary Drug Delivery Devices Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Inhalation Pulmonary Drug Delivery Devices Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Inhalation Pulmonary Drug Delivery Devices Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Application (2021-2026) Table 44. Global Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Application (2027-2032) Table 45. Global Inhalation Pulmonary Drug Delivery Devices Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 46. Global Inhalation Pulmonary Drug Delivery Devices Sales by Region (2021-2026) & (K Units) Table 47. Global Inhalation Pulmonary Drug Delivery Devices Sales Market Share by Region (2021-2026) Table 48. Global Inhalation Pulmonary Drug Delivery Devices Sales by Region (2027-2032) & (K Units) Table 49. Global Inhalation Pulmonary Drug Delivery Devices Sales Market Share by Region (2027-2032) Table 50. Global Inhalation Pulmonary Drug Delivery Devices Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Inhalation Pulmonary Drug Delivery Devices Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Region (2021-2026) Table 53. Global Inhalation Pulmonary Drug Delivery Devices Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Region (2027-2032) Table 55. Global Inhalation Pulmonary Drug Delivery Devices Market Average Price (US$/Unit) by Region (2021-2026) Table 56. Global Inhalation Pulmonary Drug Delivery Devices Market Average Price (US$/Unit) by Region (2027-2032) Table 57. Global Inhalation Pulmonary Drug Delivery Devices Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. Global Inhalation Pulmonary Drug Delivery Devices Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Inhalation Pulmonary Drug Delivery Devices Sales by Country (2021-2026) & (K Units) Table 60. Global Inhalation Pulmonary Drug Delivery Devices Sales Market Share by Country (2021-2026) Table 61. Global Inhalation Pulmonary Drug Delivery Devices Sales by Country (2027-2032) & (K Units) Table 62. Global Inhalation Pulmonary Drug Delivery Devices Sales Market Share by Country (2027-2032) Table 63. Global Inhalation Pulmonary Drug Delivery Devices Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Inhalation Pulmonary Drug Delivery Devices Sales Value Market Share by Country (2021-2026) Table 65. Global Inhalation Pulmonary Drug Delivery Devices Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Inhalation Pulmonary Drug Delivery Devices Sales Value Market Share by Country (2027-2032) Table 67. AptarGroup Company Information Table 68. AptarGroup Business Overview Table 69. AptarGroup Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. AptarGroup Inhalation Pulmonary Drug Delivery Devices Product Portfolio Table 71. AptarGroup Recent Development Table 72. Boehringer Ingelheim Company Information Table 73. Boehringer Ingelheim Business Overview Table 74. Boehringer Ingelheim Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Boehringer Ingelheim Inhalation Pulmonary Drug Delivery Devices Product Portfolio Table 76. Boehringer Ingelheim Recent Development Table 77. Chiesi Farmaceutici Company Information Table 78. Chiesi Farmaceutici Business Overview Table 79. Chiesi Farmaceutici Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Chiesi Farmaceutici Inhalation Pulmonary Drug Delivery Devices Product Portfolio Table 81. Chiesi Farmaceutici Recent Development Table 82. H&T Presspart Company Information Table 83. H&T Presspart Business Overview Table 84. H&T Presspart Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. H&T Presspart Inhalation Pulmonary Drug Delivery Devices Product Portfolio Table 86. H&T Presspart Recent Development Table 87. Koninklijke Philips Company Information Table 88. Koninklijke Philips Business Overview Table 89. Koninklijke Philips Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Koninklijke Philips Inhalation Pulmonary Drug Delivery Devices Product Portfolio Table 91. Koninklijke Philips Recent Development Table 92. Monaghan Medical Company Information Table 93. Monaghan Medical Business Overview Table 94. Monaghan Medical Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Monaghan Medical Inhalation Pulmonary Drug Delivery Devices Product Portfolio Table 96. Monaghan Medical Recent Development Table 97. OMRON Company Information Table 98. OMRON Business Overview Table 99. OMRON Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. OMRON Inhalation Pulmonary Drug Delivery Devices Product Portfolio Table 101. OMRON Recent Development Table 102. PARI International Company Information Table 103. PARI International Business Overview Table 104. PARI International Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. PARI International Inhalation Pulmonary Drug Delivery Devices Product Portfolio Table 106. PARI International Recent Development Table 107. Vectura Company Information Table 108. Vectura Business Overview Table 109. Vectura Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Vectura Inhalation Pulmonary Drug Delivery Devices Product Portfolio Table 111. Vectura Recent Development Table 112. AstraZeneca Company Information Table 113. AstraZeneca Business Overview Table 114. AstraZeneca Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. AstraZeneca Inhalation Pulmonary Drug Delivery Devices Product Portfolio Table 116. AstraZeneca Recent Development Table 117. GlaxoSmithKline (GSK) Company Information Table 118. GlaxoSmithKline (GSK) Business Overview Table 119. GlaxoSmithKline (GSK) Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. GlaxoSmithKline (GSK) Inhalation Pulmonary Drug Delivery Devices Product Portfolio Table 121. GlaxoSmithKline (GSK) Recent Development Table 122. Viatris Company Information Table 123. Viatris Business Overview Table 124. Viatris Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Viatris Inhalation Pulmonary Drug Delivery Devices Product Portfolio Table 126. Viatris Recent Development Table 127. Merck Company Information Table 128. Merck Business Overview Table 129. Merck Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Merck Inhalation Pulmonary Drug Delivery Devices Product Portfolio Table 131. Merck Recent Development Table 132. Novartis Company Information Table 133. Novartis Business Overview Table 134. Novartis Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Novartis Inhalation Pulmonary Drug Delivery Devices Product Portfolio Table 136. Novartis Recent Development Table 137. Teva Pharmaceutical Industries Company Information Table 138. Teva Pharmaceutical Industries Business Overview Table 139. Teva Pharmaceutical Industries Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Teva Pharmaceutical Industries Inhalation Pulmonary Drug Delivery Devices Product Portfolio Table 141. Teva Pharmaceutical Industries Recent Development Table 142. Key Raw Materials Table 143. Raw Materials Key Suppliers Table 144. Inhalation Pulmonary Drug Delivery Devices Distributors List Table 145. Inhalation Pulmonary Drug Delivery Devices Customers List Table 146. Research Programs/Design for This Report Table 147. Authors List of This Report Table 148. Secondary Sources Table 149. Primary Sources List of Figures Figure 1. Inhalation Pulmonary Drug Delivery Devices Product Image Figure 2. Global Inhalation Pulmonary Drug Delivery Devices Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Inhalation Pulmonary Drug Delivery Devices Sales Value (2021-2032) & (US$ Million) Figure 4. Global Inhalation Pulmonary Drug Delivery Devices Sales (2021-2032) & (K Units) Figure 5. Global Inhalation Pulmonary Drug Delivery Devices Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Inhalation Pulmonary Drug Delivery Devices Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Nebulizers Image Figure 10. Dry-powder Inhalers Image Figure 11. Metered- dose Inhalers Image Figure 12. Global Inhalation Pulmonary Drug Delivery Devices Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Inhalation Pulmonary Drug Delivery Devices Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Inhalation Pulmonary Drug Delivery Devices Sales Volume Share by Type (2021-2032) Figure 15. Global Inhalation Pulmonary Drug Delivery Devices Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Inhalation Pulmonary Drug Delivery Devices Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Type (2021-2032) Figure 18. Chronic Obstructive Pulmonary Disease (COPD) Image Figure 19. Cystic Fibrosis (CF) Image Figure 20. Idiopathic Pulmonary Fibrosis (IPF) Image Figure 21. Asthma Image Figure 22. Others Image Figure 23. Global Inhalation Pulmonary Drug Delivery Devices Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Inhalation Pulmonary Drug Delivery Devices Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Inhalation Pulmonary Drug Delivery Devices Sales Volume Share by Application (2021-2032) Figure 26. Global Inhalation Pulmonary Drug Delivery Devices Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Inhalation Pulmonary Drug Delivery Devices Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Application (2021-2032) Figure 29. Global Inhalation Pulmonary Drug Delivery Devices Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 30. Global Inhalation Pulmonary Drug Delivery Devices Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Inhalation Pulmonary Drug Delivery Devices Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Inhalation Pulmonary Drug Delivery Devices Sales Value (2021-2032) & (US$ Million) Figure 34. North America Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Inhalation Pulmonary Drug Delivery Devices Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Inhalation Pulmonary Drug Delivery Devices Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Inhalation Pulmonary Drug Delivery Devices Sales Value (2021-2032) & (US$ Million) Figure 40. South America Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Inhalation Pulmonary Drug Delivery Devices Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Inhalation Pulmonary Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Inhalation Pulmonary Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Inhalation Pulmonary Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Inhalation Pulmonary Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Inhalation Pulmonary Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Inhalation Pulmonary Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Inhalation Pulmonary Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Inhalation Pulmonary Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Inhalation Pulmonary Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Inhalation Pulmonary Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Inhalation Pulmonary Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Inhalation Pulmonary Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Inhalation Pulmonary Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Inhalation Pulmonary Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Inhalation Pulmonary Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Inhalation Pulmonary Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Inhalation Pulmonary Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Inhalation Pulmonary Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Inhalation Pulmonary Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Inhalation Pulmonary Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Inhalation Pulmonary Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Inhalation Pulmonary Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Inhalation Pulmonary Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Inhalation Pulmonary Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Inhalation Pulmonary Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Inhalation Pulmonary Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Inhalation Pulmonary Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Inhalation Pulmonary Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Inhalation Pulmonary Drug Delivery Devices Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Inhalation Pulmonary Drug Delivery Devices Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Nebulizers
  • Dry-powder Inhalers
  • Metered- dose Inhalers
Applications
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Cystic Fibrosis (CF)
  • Idiopathic Pulmonary Fibrosis (IPF)
  • Asthma
  • Others
Companies covered
  • AptarGroup
  • Boehringer Ingelheim
  • Chiesi Farmaceutici
  • H&T Presspart
  • Koninklijke Philips
  • Monaghan Medical
  • OMRON
  • PARI International
  • Vectura
  • AstraZeneca
  • GlaxoSmithKline (GSK)
  • Viatris
  • Merck
  • Novartis
  • Teva Pharmaceutical Industries

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Inhalation Pulmonary Drug Delivery Devices Sales Value (2021-2032)
  4. 1.2.2 Global Inhalation Pulmonary Drug Delivery Devices Sales Volume (2021-2032)
  5. 1.2.3 Global Inhalation Pulmonary Drug Delivery Devices Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Inhalation Pulmonary Drug Delivery Devices Market Dynamics
  1. 2.1 Inhalation Pulmonary Drug Delivery Devices Industry Trends
  2. 2.2 Inhalation Pulmonary Drug Delivery Devices Industry Drivers
  3. 2.3 Inhalation Pulmonary Drug Delivery Devices Industry Opportunities and Challenges
  4. 2.4 Inhalation Pulmonary Drug Delivery Devices Industry Restraints
3 Inhalation Pulmonary Drug Delivery Devices Market by Company
  1. 3.1 Global Inhalation Pulmonary Drug Delivery Devices Company Revenue Ranking in 2025
  2. 3.2 Global Inhalation Pulmonary Drug Delivery Devices Revenue by Company (2021-2026)
  3. 3.3 Global Inhalation Pulmonary Drug Delivery Devices Sales Volume by Company (2021-2026)
  4. 3.4 Global Inhalation Pulmonary Drug Delivery Devices Average Price by Company (2021-2026)
  5. 3.5 Global Inhalation Pulmonary Drug Delivery Devices Company Ranking (2024-2026)
  6. 3.6 Global Inhalation Pulmonary Drug Delivery Devices Company Manufacturing Base and Headquarters
  7. 3.7 Global Inhalation Pulmonary Drug Delivery Devices Company Product Type and Application
  8. 3.8 Global Inhalation Pulmonary Drug Delivery Devices Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Inhalation Pulmonary Drug Delivery Devices Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Inhalation Pulmonary Drug Delivery Devices Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Inhalation Pulmonary Drug Delivery Devices Market by Type
  1. 4.1 Inhalation Pulmonary Drug Delivery Devices Type Introduction
  2. 4.1.1 Nebulizers
  3. 4.1.2 Dry-powder Inhalers
  4. 4.1.3 Metered- dose Inhalers
  5. 4.2 Global Inhalation Pulmonary Drug Delivery Devices Sales Volume by Type
  6. 4.2.1 Global Inhalation Pulmonary Drug Delivery Devices Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Inhalation Pulmonary Drug Delivery Devices Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Inhalation Pulmonary Drug Delivery Devices Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Inhalation Pulmonary Drug Delivery Devices Sales Value by Type
  10. 4.3.1 Global Inhalation Pulmonary Drug Delivery Devices Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Inhalation Pulmonary Drug Delivery Devices Sales Value by Type (2021-2032)
  12. 4.3.3 Global Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Type (2021-2032)
5 Inhalation Pulmonary Drug Delivery Devices Market by Application
  1. 5.1 Inhalation Pulmonary Drug Delivery Devices Application Introduction
  2. 5.1.1 Chronic Obstructive Pulmonary Disease (COPD)
  3. 5.1.2 Cystic Fibrosis (CF)
  4. 5.1.3 Idiopathic Pulmonary Fibrosis (IPF)
  5. 5.1.4 Asthma
  6. 5.1.5 Others
  7. 5.2 Global Inhalation Pulmonary Drug Delivery Devices Sales Volume by Application
  8. 5.2.1 Global Inhalation Pulmonary Drug Delivery Devices Sales Volume by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Inhalation Pulmonary Drug Delivery Devices Sales Volume by Application (2021-2032)
  10. 5.2.3 Global Inhalation Pulmonary Drug Delivery Devices Sales Volume Share by Application (2021-2032)
  11. 5.3 Global Inhalation Pulmonary Drug Delivery Devices Sales Value by Application
  12. 5.3.1 Global Inhalation Pulmonary Drug Delivery Devices Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Inhalation Pulmonary Drug Delivery Devices Sales Value by Application (2021-2032)
  14. 5.3.3 Global Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Application (2021-2032)
6 Inhalation Pulmonary Drug Delivery Devices Regional Sales and Value Analysis
  1. 6.1 Global Inhalation Pulmonary Drug Delivery Devices Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Inhalation Pulmonary Drug Delivery Devices Sales by Region (2021-2032)
  3. 6.2.1 Global Inhalation Pulmonary Drug Delivery Devices Sales by Region: 2021-2026
  4. 6.2.2 Global Inhalation Pulmonary Drug Delivery Devices Sales by Region (2027-2032)
  5. 6.3 Global Inhalation Pulmonary Drug Delivery Devices Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Inhalation Pulmonary Drug Delivery Devices Sales Value by Region (2021-2032)
  7. 6.4.1 Global Inhalation Pulmonary Drug Delivery Devices Sales Value by Region: 2021-2026
  8. 6.4.2 Global Inhalation Pulmonary Drug Delivery Devices Sales Value by Region (2027-2032)
  9. 6.5 Global Inhalation Pulmonary Drug Delivery Devices Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Inhalation Pulmonary Drug Delivery Devices Sales Value (2021-2032)
  12. 6.6.2 North America Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Inhalation Pulmonary Drug Delivery Devices Sales Value (2021-2032)
  15. 6.7.2 Europe Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Inhalation Pulmonary Drug Delivery Devices Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Inhalation Pulmonary Drug Delivery Devices Sales Value (2021-2032)
  21. 6.9.2 South America Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Inhalation Pulmonary Drug Delivery Devices Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Country, 2025 VS 2032
7 Inhalation Pulmonary Drug Delivery Devices Country-level Sales and Value Analysis
  1. 7.1 Global Inhalation Pulmonary Drug Delivery Devices Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Inhalation Pulmonary Drug Delivery Devices Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Inhalation Pulmonary Drug Delivery Devices Sales by Country (2021-2032)
  4. 7.3.1 Global Inhalation Pulmonary Drug Delivery Devices Sales by Country (2021-2026)
  5. 7.3.2 Global Inhalation Pulmonary Drug Delivery Devices Sales by Country (2027-2032)
  6. 7.4 Global Inhalation Pulmonary Drug Delivery Devices Sales Value by Country (2021-2032)
  7. 7.4.1 Global Inhalation Pulmonary Drug Delivery Devices Sales Value by Country (2021-2026)
  8. 7.4.2 Global Inhalation Pulmonary Drug Delivery Devices Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Inhalation Pulmonary Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Inhalation Pulmonary Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Inhalation Pulmonary Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Inhalation Pulmonary Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Inhalation Pulmonary Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Inhalation Pulmonary Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Inhalation Pulmonary Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Inhalation Pulmonary Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Inhalation Pulmonary Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Inhalation Pulmonary Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Inhalation Pulmonary Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Inhalation Pulmonary Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Inhalation Pulmonary Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Inhalation Pulmonary Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Inhalation Pulmonary Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Inhalation Pulmonary Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Inhalation Pulmonary Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Inhalation Pulmonary Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Inhalation Pulmonary Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Inhalation Pulmonary Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Inhalation Pulmonary Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Inhalation Pulmonary Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Inhalation Pulmonary Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Inhalation Pulmonary Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Inhalation Pulmonary Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Inhalation Pulmonary Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Inhalation Pulmonary Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Inhalation Pulmonary Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Inhalation Pulmonary Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 AptarGroup
  2. 8.1.1 AptarGroup Company Information
  3. 8.1.2 AptarGroup Business Overview
  4. 8.1.3 AptarGroup Inhalation Pulmonary Drug Delivery Devices Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 AptarGroup Inhalation Pulmonary Drug Delivery Devices Product Portfolio
  6. 8.1.5 AptarGroup Recent Developments
  7. 8.2 Boehringer Ingelheim
  8. 8.2.1 Boehringer Ingelheim Company Information
  9. 8.2.2 Boehringer Ingelheim Business Overview
  10. 8.2.3 Boehringer Ingelheim Inhalation Pulmonary Drug Delivery Devices Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Boehringer Ingelheim Inhalation Pulmonary Drug Delivery Devices Product Portfolio
  12. 8.2.5 Boehringer Ingelheim Recent Developments
  13. 8.3 Chiesi Farmaceutici
  14. 8.3.1 Chiesi Farmaceutici Company Information
  15. 8.3.2 Chiesi Farmaceutici Business Overview
  16. 8.3.3 Chiesi Farmaceutici Inhalation Pulmonary Drug Delivery Devices Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Chiesi Farmaceutici Inhalation Pulmonary Drug Delivery Devices Product Portfolio
  18. 8.3.5 Chiesi Farmaceutici Recent Developments
  19. 8.4 H&T Presspart
  20. 8.4.1 H&T Presspart Company Information
  21. 8.4.2 H&T Presspart Business Overview
  22. 8.4.3 H&T Presspart Inhalation Pulmonary Drug Delivery Devices Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 H&T Presspart Inhalation Pulmonary Drug Delivery Devices Product Portfolio
  24. 8.4.5 H&T Presspart Recent Developments
  25. 8.5 Koninklijke Philips
  26. 8.5.1 Koninklijke Philips Company Information
  27. 8.5.2 Koninklijke Philips Business Overview
  28. 8.5.3 Koninklijke Philips Inhalation Pulmonary Drug Delivery Devices Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Koninklijke Philips Inhalation Pulmonary Drug Delivery Devices Product Portfolio
  30. 8.5.5 Koninklijke Philips Recent Developments
  31. 8.6 Monaghan Medical
  32. 8.6.1 Monaghan Medical Company Information
  33. 8.6.2 Monaghan Medical Business Overview
  34. 8.6.3 Monaghan Medical Inhalation Pulmonary Drug Delivery Devices Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Monaghan Medical Inhalation Pulmonary Drug Delivery Devices Product Portfolio
  36. 8.6.5 Monaghan Medical Recent Developments
  37. 8.7 OMRON
  38. 8.7.1 OMRON Company Information
  39. 8.7.2 OMRON Business Overview
  40. 8.7.3 OMRON Inhalation Pulmonary Drug Delivery Devices Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 OMRON Inhalation Pulmonary Drug Delivery Devices Product Portfolio
  42. 8.7.5 OMRON Recent Developments
  43. 8.8 PARI International
  44. 8.8.1 PARI International Company Information
  45. 8.8.2 PARI International Business Overview
  46. 8.8.3 PARI International Inhalation Pulmonary Drug Delivery Devices Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 PARI International Inhalation Pulmonary Drug Delivery Devices Product Portfolio
  48. 8.8.5 PARI International Recent Developments
  49. 8.9 Vectura
  50. 8.9.1 Vectura Company Information
  51. 8.9.2 Vectura Business Overview
  52. 8.9.3 Vectura Inhalation Pulmonary Drug Delivery Devices Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Vectura Inhalation Pulmonary Drug Delivery Devices Product Portfolio
  54. 8.9.5 Vectura Recent Developments
  55. 8.10 AstraZeneca
  56. 8.10.1 AstraZeneca Company Information
  57. 8.10.2 AstraZeneca Business Overview
  58. 8.10.3 AstraZeneca Inhalation Pulmonary Drug Delivery Devices Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 AstraZeneca Inhalation Pulmonary Drug Delivery Devices Product Portfolio
  60. 8.10.5 AstraZeneca Recent Developments
  61. 8.11 GlaxoSmithKline (GSK)
  62. 8.11.1 GlaxoSmithKline (GSK) Company Information
  63. 8.11.2 GlaxoSmithKline (GSK) Business Overview
  64. 8.11.3 GlaxoSmithKline (GSK) Inhalation Pulmonary Drug Delivery Devices Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 GlaxoSmithKline (GSK) Inhalation Pulmonary Drug Delivery Devices Product Portfolio
  66. 8.11.5 GlaxoSmithKline (GSK) Recent Developments
  67. 8.12 Viatris
  68. 8.12.1 Viatris Company Information
  69. 8.12.2 Viatris Business Overview
  70. 8.12.3 Viatris Inhalation Pulmonary Drug Delivery Devices Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Viatris Inhalation Pulmonary Drug Delivery Devices Product Portfolio
  72. 8.12.5 Viatris Recent Developments
  73. 8.13 Merck
  74. 8.13.1 Merck Company Information
  75. 8.13.2 Merck Business Overview
  76. 8.13.3 Merck Inhalation Pulmonary Drug Delivery Devices Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Merck Inhalation Pulmonary Drug Delivery Devices Product Portfolio
  78. 8.13.5 Merck Recent Developments
  79. 8.14 Novartis
  80. 8.14.1 Novartis Company Information
  81. 8.14.2 Novartis Business Overview
  82. 8.14.3 Novartis Inhalation Pulmonary Drug Delivery Devices Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Novartis Inhalation Pulmonary Drug Delivery Devices Product Portfolio
  84. 8.14.5 Novartis Recent Developments
  85. 8.15 Teva Pharmaceutical Industries
  86. 8.15.1 Teva Pharmaceutical Industries Company Information
  87. 8.15.2 Teva Pharmaceutical Industries Business Overview
  88. 8.15.3 Teva Pharmaceutical Industries Inhalation Pulmonary Drug Delivery Devices Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Teva Pharmaceutical Industries Inhalation Pulmonary Drug Delivery Devices Product Portfolio
  90. 8.15.5 Teva Pharmaceutical Industries Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Inhalation Pulmonary Drug Delivery Devices Value Chain Analysis
  2. 9.1.1 Inhalation Pulmonary Drug Delivery Devices Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Inhalation Pulmonary Drug Delivery Devices Sales Mode & Process
  6. 9.2 Inhalation Pulmonary Drug Delivery Devices Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Inhalation Pulmonary Drug Delivery Devices Distributors
  9. 9.2.3 Inhalation Pulmonary Drug Delivery Devices Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst